ABSTRACT
Levetiracetam (LEV) is a pyrrolidine derivative antiepileptic medication used for the treatment of seizures in pediatric and adult patients. We report a case of probable LEV-induced aseptic meningitis in a 13-year-old girl. The patient received LEV for a generalized seizure disorder and presented with symptoms 5 days after medication initiation. Ten days after LEV initiation, the patient presented to the hospital for further management. During her hospital course, infectious etiologies were ruled out with clinical and diagnostic testing. Upon discontinuation of LEV, the patient's symptoms resolved. Although select antiepileptic medications have been associated with drug-induced aseptic meningitis (DIAM), to date, no reports have been published about DIAM following the administration of LEV. We describe and categorize the probability of DIAM in association with LEV, as observed in a patient case.
Subject(s)
Anticonvulsants/adverse effects , Levetiracetam/adverse effects , Meningitis, Aseptic/chemically induced , Adolescent , Anticonvulsants/administration & dosage , Epilepsy, Generalized/drug therapy , Female , Humans , Levetiracetam/administration & dosage , Meningitis, Aseptic/diagnosisSubject(s)
Antitubercular Agents/therapeutic use , Consciousness Disorders/etiology , Tuberculosis, Meningeal/diagnosis , Brain/diagnostic imaging , Child, Preschool , Humans , Infant , Magnetic Resonance Imaging , Male , Siblings , Tomography, X-Ray Computed , Tuberculosis, Meningeal/complications , Tuberculosis, Meningeal/drug therapyABSTRACT
The male:female ratio in autism spectrum disorder (ASD) averages greater than 4:1 while the male:female ratio of ASD with epilepsy averages less than 3:1. This indicates an elevated risk of epilepsy in females with ASD; yet, it is unknown whether phenotypic features of epilepsy and ASD differ between males and females with this comorbidity. The goal of this study is to investigate sex differences in phenotypic features of epilepsy and ASD in a prospective sample of 130 children and young adults with an initial ASD diagnosis and subsequent epilepsy diagnosis. All participants were characterized by standardized diagnostic inventories, parent/caregiver completed questionnaires, and medical/academic record review. Diagnostic classifications of epilepsy, ASD, and intellectual disability were performed by board certified neurologists and a pediatric neuropsychologist. Results demonstrated a lower male:female ratio (1.8:1) in individuals with ASD and treatment-resistant epilepsy relative to those with ASD and treatment-responsive epilepsy (4.9:1), indicating a higher risk of treatment-resistant epilepsy in females. Mild neuroimaging abnormalities were more common in females than males and this was associated with increased risk of treatment-resistance. In contrast, ASD symptom severity was lower in females compared with males. Findings distinguish females with ASD and epilepsy as a distinct subgroup at higher risk for a more severe epilepsy phenotype in the context of a less severe ASD phenotype. Increased risk of anti-epileptic treatment resistance in females with ASD and epilepsy suggests that comprehensive genetic, imaging, and neurologic screening and enhanced treatment monitoring may be indicated for this subgroup. Autism Res 2016, 9: 311-320. © 2015 International Society for Autism Research, Wiley Periodicals, Inc.
Subject(s)
Autism Spectrum Disorder/epidemiology , Epilepsy/epidemiology , Adolescent , Adult , Child , Child, Preschool , Comorbidity , Female , Humans , Male , Prospective Studies , Risk , Sex Distribution , Young AdultSubject(s)
Brain Neoplasms/diagnosis , Brain Neoplasms/pathology , Germinoma/diagnosis , Germinoma/pathology , Meningitis, Fungal/diagnosis , Meningitis, Fungal/pathology , beta-Glucans/cerebrospinal fluid , Adolescent , Diagnosis, Differential , False Positive Reactions , Humans , Male , ProteoglycansSubject(s)
Cystic Fibrosis/diagnosis , Hepatitis, Autoimmune/diagnosis , Portal Vein/abnormalities , Vascular Malformations/diagnosis , Ataxia/etiology , Child , Child, Preschool , Cholestasis/etiology , Cystic Fibrosis/therapy , Diagnosis, Differential , Disorders of Excessive Somnolence/etiology , Failure to Thrive/etiology , Fatigue/etiology , Female , Hepatitis, Autoimmune/therapy , Humans , Infant , Jaundice/etiology , MaleABSTRACT
Neonatal alloimmune thrombocytopenia with intracranial hemorrhage is a reported phenomenon. While most of the hemorrhages are noted to be either intraventricular or intraparenchymal, the authors describe the case of a fourth-ventricle hemorrhage with extension into the spinal column down the cervical spinal cord secondary to maternal anti-human platelet antigen (HPA-1a) antibody.
